Amanote Research
Register
Sign In
Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer
Cancer Research
- United States
doi 10.1158/0008-5472.can-09-3215
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
January 26, 2010
Authors
X. Yan
J. Yin
H. Yao
N. Mao
Y. Yang
L. Pan
Publisher
American Association for Cancer Research (AACR)
Related search
Downregulation of Vimentin Expression Increased Drug Resistance in Ovarian Cancer Cells
Oncotarget
Oncology
Exosomes as Mediators of Platinum Resistance in Ovarian Cancer
Oncotarget
Oncology
Increased Expression of Metallothionein Is Associated With Irinotecan Resistance in Gastric Cancer
Cancer Research
Cancer Research
Oncology
TCRP1 Expression Is Associated With Platinum Sensitivity in Human Lung and Ovarian Cancer Cells
Oncology Letters
Cancer Research
Oncology
Is HIPEC Beneficial in Platinum Resistant Relapsed Ovarian Cancer?
Romanian Journal of Medical Practice
Reduced Expression of P27 Is a Novel Mechanism of Docetaxel Resistance in Breast Cancer Cells
Breast Cancer Research
Cancer Research
Oncology
Annexin A4 Induces Platinum Resistance in a Chloride-And Calcium-Dependent Manner
Oncotarget
Oncology
Stromal Annexin A2 Expression Is Predictive of Decreased Survival in Pancreatic Cancer
Oncotarget
Oncology
Reversing Platinum Resistance in Ovarian Cancer Multicellular Spheroids by Targeting BCL-2
OncoTargets and Therapy
Oncology
Pharmacology